| HOME SITE MAP CONTACT US | |||
![]() |
Preclinical Capabilities About ADMETRx, Inc. ADMETRx focuses on redefining drug discovery everyday. Our multi-criteria optimization approaches will apply to all stages of discovery and development, using all information available. With our extensive big Pharma experience and widely acknowledged ADME expertise, we have developed a more effective means of problem-solving in drug discovery. Our customers deserve more than the traditional “go/no-go” decision-making model that has historically been used to select which drug candidates are advanced through the various discovery and development phases. Instead, we show our customers the potential compensatory trade-offs in a compound’s properties that, when balanced, promote successful lead selection and optimization, and ultimately successful in vivo performance. This process of knowledge-based guidance can lead to improved effectiveness overall, often demonstrated by expedited timeframes and reduced developmental costs. copyright © 2008. Kalexsyn, Inc. |
| |